Last update 04 Jul 2025

ID-11916

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ID 11916, ID-11916, ID-119160021
+ [2]
Target
AR x PDE5A
Action
antagonists, inhibitors
Mechanism
AR antagonists(Androgen Receptor antagonists), PDE5A inhibitors(Phosphodiesterase 5A inhibitors)
Therapeutic Areas
NeoplasmsNervous System DiseasesSkin and Musculoskeletal Diseases+ [2]
Active Indication
Castration-Resistant Prostatic CancerGlioblastomaTriple Negative Breast Cancer
Inactive Indication-
Originator Organization
Idience Co., Ltd.Idience Co., Ltd.
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
Active Organization
Idience Co., Ltd.Idience Co., Ltd.
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with ID-11916
Login to view more data
100 Translational Medicine associated with ID-11916
Login to view more data
100 Patents (Medical) associated with ID-11916
Login to view more data
100 Deals associated with ID-11916
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Castration-Resistant Prostatic CancerPreclinical
South Korea
Idience Co., Ltd.Idience Co., Ltd.
01 Jul 2025
Castration-Resistant Prostatic CancerPreclinical
South Korea
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
01 Jul 2025
GlioblastomaPreclinical
South Korea
Idience Co., Ltd.Idience Co., Ltd.
01 Jul 2025
GlioblastomaPreclinical
South Korea
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
01 Jul 2025
Triple Negative Breast CancerPreclinical
South Korea
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
01 Jul 2025
Triple Negative Breast CancerPreclinical
South Korea
Idience Co., Ltd.Idience Co., Ltd.
01 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free